Ultime Notizie Molmed News
Relazione sulla Remunerazione MolMed S.p.A.
MolMed now part of AGC Biologics | LinkedIn
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
MolMed: Contact Details and Business Profile
MolMed now part of AGC Biologics | LinkedIn
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Frontiers | Modulation of Reactive Oxygen Species Homeostasis as a Pleiotropic Effect of Commonly Used Drugs
L'ok Ue fa volare Molmed (+11%) - MilanoFinanza.it
Il 2019 è l'anno della svolta per MolMed - MilanoFinanza.it
Sergio Signore (@signore_sergio) / Twitter
MolMed - YouTube
MolMed - Wikipedia
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Overview of the Italian Primary Markets
Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
MolMed: AIFA approva commercializzazione Zalmoxis. Titolo vola in Borsa - Economia e Finanza - Repubblica.it
COMUNICATO STAMPA
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
MolMed, viaggio nell'officina dei superfarmaci per le terapie geniche - Il Sole 24 ORE
Voluntary Tender Offer launched by AGC Inc. on all ordinary shares of MolMed: the Board of Directors approves the Issuer's not
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
